Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 898

1.

Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Eslami L, Merat S, Malekzadeh R, Nasseri-Moghaddam S, Aramin H.

Cochrane Database Syst Rev. 2013 Dec 27;(12):CD008623. doi: 10.1002/14651858.CD008623.pub2. Review.

PMID:
24374462
2.

HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.

Lewicki M, Ng I, Schneider AG.

Cochrane Database Syst Rev. 2015 Mar 11;(3):CD010480. doi: 10.1002/14651858.CD010480.pub2. Review.

PMID:
25758322
3.

Herbal medicines for fatty liver diseases.

Liu ZL, Xie LZ, Zhu J, Li GQ, Grant SJ, Liu JP.

Cochrane Database Syst Rev. 2013 Aug 24;(8):CD009059. doi: 10.1002/14651858.CD009059.pub2. Review.

PMID:
23975682
4.

Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.

Lombardi R, Onali S, Thorburn D, Davidson BR, Gurusamy KS, Tsochatzis E.

Cochrane Database Syst Rev. 2017 Mar 30;3:CD011640. doi: 10.1002/14651858.CD011640.pub2. Review.

PMID:
28358980
5.

Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.

Angelico F, Burattin M, Alessandri C, Del Ben M, Lirussi F.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD005166. Review.

PMID:
17253544
6.

Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis.

Lirussi F, Azzalini L, Orando S, Orlando R, Angelico F.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004996. Review.

PMID:
17253535
7.

Bezafibrate for primary biliary cirrhosis.

Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD009145. doi: 10.1002/14651858.CD009145.pub2. Review.

PMID:
22259000
8.

Statins for the treatment of dementia.

McGuinness B, O'Hare J, Craig D, Bullock R, Malouf R, Passmore P.

Cochrane Database Syst Rev. 2010 Aug 4;(8):CD007514. doi: 10.1002/14651858.CD007514.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;7:CD007514.

PMID:
20687089
9.

Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.

Sanders RD, Nicholson A, Lewis SR, Smith AF, Alderson P.

Cochrane Database Syst Rev. 2013 Jul 3;(7):CD009971. doi: 10.1002/14651858.CD009971.pub2. Review.

PMID:
23824754
10.

Statins for age-related macular degeneration.

Gehlbach P, Li T, Hatef E.

Cochrane Database Syst Rev. 2015 Feb 11;(2):CD006927. doi: 10.1002/14651858.CD006927.pub4. Review. Update in: Cochrane Database Syst Rev. 2016;(8):CD006927.

11.

Ursodeoxycholic acid for primary biliary cirrhosis.

Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD000551. doi: 10.1002/14651858.CD000551.pub3. Review.

PMID:
23235576
12.
13.

Interferon alpha for chronic hepatitis D.

Abbas Z, Khan MA, Salih M, Jafri W.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006002. doi: 10.1002/14651858.CD006002.pub2. Review.

PMID:
22161394
14.

Fibrates for primary prevention of cardiovascular disease events.

Jakob T, Nordmann AJ, Schandelmaier S, Ferreira-González I, Briel M.

Cochrane Database Syst Rev. 2016 Nov 16;11:CD009753. Review.

PMID:
27849333
15.

Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis.

Orlando R, Azzalini L, Orando S, Lirussi F.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD005160. Review.

PMID:
17253541
16.

Statins for the treatment of dementia.

McGuinness B, Craig D, Bullock R, Malouf R, Passmore P.

Cochrane Database Syst Rev. 2014 Jul 8;(7):CD007514. doi: 10.1002/14651858.CD007514.pub3. Review.

PMID:
25004278
17.

Lipid-lowering agents for nephrotic syndrome.

Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L.

Cochrane Database Syst Rev. 2013 Dec 10;(12):CD005425. doi: 10.1002/14651858.CD005425.pub2. Review.

PMID:
24327265
18.

Statins for women with polycystic ovary syndrome not actively trying to conceive.

Raval AD, Hunter T, Stuckey B, Hart RJ.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD008565. doi: 10.1002/14651858.CD008565.pub2. Review.

PMID:
21975784
19.

Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study.

Athyros VG, Mikhailidis DP, Didangelos TP, Giouleme OI, Liberopoulos EN, Karagiannis A, Kakafika AI, Tziomalos K, Burroughs AK, Elisaf MS.

Curr Med Res Opin. 2006 May;22(5):873-83.

PMID:
16709309
20.

An economic analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS).

Smith DG, McBurney CR.

Pharmacoeconomics. 2003;21 Suppl 1:13-23.

PMID:
12648031

Supplemental Content

Support Center